最後更新
成分股列表
Vanguard Health Care Index Fund(VHT) 成分股。透過此分析ETF所持有的個股有哪些,並可進一步分析個股的合理價與價值區間。
排名 | 代碼 | 名稱 | 比例 |
---|---|---|---|
1 | LLY | Eli Lilly & Co. | 10.1% |
2 | UNH | UnitedHealth Group Inc. | 7.36% |
3 | JNJ | Johnson & Johnson | 6.13% |
4 | MRK | Merck & Co. Inc. | 5.38% |
5 | ABBV | AbbVie Inc. | 5.17% |
6 | TMO | Thermo Fisher Scientific Inc. | 3.61% |
7 | ABT | Abbott Laboratories | 3.17% |
8 | DHR | Danaher Corp. | 2.82% |
9 | PFE | Pfizer Inc. | 2.52% |
10 | AMGN | Amgen Inc. | 2.45% |
11 | ISRG | Intuitive Surgical Inc. | 2.26% |
12 | SYK | Stryker Corp. | 1.97% |
13 | ELV | Anthem Inc. | 1.96% |
14 | MDT | Medtronic plc | 1.86% |
15 | BMY | Bristol-Myers Squibb Co. | 1.77% |
16 | VRTX | Vertex Pharmaceuticals Inc. | 1.73% |
17 | CI | Cigna Corp. | 1.71% |
18 | REGN | Regeneron Pharmaceuticals Inc. | 1.66% |
19 | CVS | CVS Health Corp. | 1.65% |
20 | BSX | Boston Scientific Corp. | 1.61% |
21 | GILD | Gilead Sciences Inc. | 1.47% |
22 | ZTS | Zoetis Inc. | 1.25% |
23 | MCK | McKesson Corp. | 1.15% |
24 | BDX | Becton Dickinson and Co. | 1.15% |
25 | HCA | HCA Healthcare Inc. | 1.08% |
26 | EW | Edwards Lifesciences Corp. | 0.93% |
27 | DXCM | DexCom Inc. | 0.86% |
28 | IQV | IQVIA Holdings Inc. | 0.74% |
29 | IDXX | IDEXX Laboratories Inc. | 0.72% |
30 | HUM | Humana Inc. | 0.69% |
31 | A | Agilent Technologies Inc. | 0.69% |
32 | CNC | Centene Corp. | 0.67% |
33 | ABC | AmerisourceBergen Corp. Class A | 0.67% |
34 | GEHC | GE HealthCare Technologies Inc. | 0.6% |
35 | VEEV | Veeva Systems Inc. Class A | 0.57% |
36 | MRNA | Moderna Inc. | 0.56% |
37 | BIIB | Biogen Inc. | 0.5% |
38 | RMD | ResMed Inc. | 0.47% |
39 | WST | West Pharmaceutical Services Inc. | 0.47% |
40 | MTD | Mettler-Toledo International Inc. | 0.46% |
41 | ZBH | Zimmer Biomet Holdings Inc. | 0.44% |
42 | CAH | Cardinal Health Inc. | 0.44% |
43 | MOH | Molina Healthcare Inc. | 0.39% |
44 | ALGN | Align Technology Inc. | 0.38% |
45 | STE | STERIS plc | 0.36% |
46 | BAX | Baxter International Inc. | 0.35% |
47 | ILMN | Illumina Inc. | 0.35% |
48 | WAT | Waters Corp. | 0.33% |
49 | COO | Cooper Cos. Inc. | 0.32% |
50 | HOLX | Hologic Inc. | 0.3% |
51 | LH | Laboratory Corp. of America Holdings | 0.3% |
52 | ALNY | Alnylam Pharmaceuticals Inc. | 0.28% |
53 | AVTR | Avantor Inc. | 0.28% |
54 | BMRN | BioMarin Pharmaceutical Inc. | 0.27% |
55 | DGX | Quest Diagnostics Inc. | 0.24% |
56 | VTRS | Viatris Inc. | 0.23% |
57 | NBIX | Neurocrine Biosciences Inc. | 0.22% |
58 | CRL | Charles River Laboratories International Inc. | 0.22% |
59 | PKI | PerkinElmer Inc. | 0.21% |
60 | EXAS | Exact Sciences Corp. | 0.2% |
61 | PODD | Insulet Corp. | 0.19% |
62 | RPRX | Royalty Pharma plc Class A | 0.19% |
63 | SWAV | Shockwave Medical Inc. | 0.19% |
64 | INCY | Incyte Corp. | 0.18% |
65 | TECH | Bio-Techne Corp. | 0.18% |
66 | UHS | Universal Health Services Inc. Class B | 0.18% |
67 | UTHR | United Therapeutics Corp. | 0.17% |
68 | TFX | Teleflex Inc. | 0.17% |
69 | NTRA | Natera Inc. | 0.17% |
70 | CTLT | Catalent Inc. | 0.16% |
71 | RGEN | Repligen Corp. | 0.16% |
72 | HSIC | Henry Schein Inc. | 0.16% |
73 | MEDP | Medpace Holdings Inc. | 0.16% |
74 | CHE | Chemed Corp. | 0.15% |
75 | THC | Tenet Healthcare Corp. | 0.15% |
76 | SRPT | Sarepta Therapeutics Inc. | 0.14% |
77 | BRKR | Bruker Corp. | 0.14% |
78 | PEN | Penumbra Inc. | 0.13% |
79 | ELAN | Elanco Animal Health Inc. | 0.13% |
80 | EHC | Encompass Health Corp. | 0.13% |
81 | JAZZ | Jazz Pharmaceuticals plc | 0.12% |
82 | BIO | Bio-Rad Laboratories Inc. Class A | 0.12% |
83 | ACHC | Acadia Healthcare Co. Inc. | 0.12% |
84 | DVA | DaVita Inc. | 0.12% |
85 | MASI | Masimo Corp. | 0.11% |
86 | XRAY | Dentsply Sirona Inc. | 0.11% |
87 | HQY | HealthEquity Inc. | 0.11% |
88 | EXEL | Exelixis Inc. | 0.11% |
89 | ENSG | Ensign Group Inc. | 0.11% |
90 | VKTX | Viking Therapeutics Inc. | 0.11% |
91 | INSP | Inspire Medical Systems Inc. | 0.1% |
92 | OPCH | Option Care Health Inc. | 0.1% |
93 | ITCI | Intra-Cellular Therapies Inc. | 0.1% |
94 | CYTK | Cytokinetics Inc. | 0.1% |
95 | PCVX | Vaxcyte Inc. | 0.1% |
96 | HALO | Halozyme Therapeutics Inc. | 0.09% |
97 | IONS | Ionis Pharmaceuticals Inc. | 0.09% |
98 | BPMC | Blueprint Medicines Corp. | 0.09% |
99 | OGN | Organon & Co. | 0.08% |
100 | CRSP | CRISPR Therapeutics AG | 0.08% |
101 | Perrigo Co. plc | 0.07% | |
102 | GMED | Globus Medical Inc. | 0.07% |
103 | APLS | Apellis Pharmaceuticals Inc. | 0.07% |
104 | LNTH | Lantheus Holdings Inc. | 0.07% |
105 | HAE | Haemonetics Corp. | 0.07% |
106 | Merit Medical Systems Inc. | 0.07% | |
107 | Alkermes plc | 0.07% | |
108 | GKOS | Glaukos Corp. | 0.07% |
109 | Envista Holdings Corp. | 0.06% | |
110 | iRhythm Technologies Inc. | 0.06% | |
111 | Arrowhead Pharmaceuticals Inc. | 0.06% | |
112 | Axonics Modulation Technologies Inc. | 0.06% | |
113 | Prestige Consumer Healthcare Inc. | 0.06% | |
114 | Ultragenyx Pharmaceutical Inc. | 0.06% | |
115 | Evolent Health Inc. Class A | 0.06% | |
116 | Insmed Inc. | 0.06% | |
117 | Integer Holdings Corp. | 0.06% | |
118 | Biohaven Ltd. | 0.06% | |
119 | Fortrea Holdings Inc. | 0.06% | |
120 | Brooks Automation Inc. | 0.05% | |
121 | Progyny Inc. | 0.05% | |
122 | Amedisys Inc. | 0.05% | |
123 | Neogen Corp. | 0.05% | |
124 | Select Medical Holdings Corp. | 0.05% | |
125 | DOCS | Doximity Inc. Class A | 0.05% |
126 | LivaNova plc | 0.05% | |
127 | Enovis Corp. | 0.05% | |
128 | 10X Genomics Inc. Class A | 0.05% | |
129 | CERE | Cerevel Therapeutics Holdings Inc. | 0.05% |
130 | KRYS | Krystal Biotech Inc. | 0.05% |
131 | RVMD | REVOLUTION Medicines Inc. | 0.05% |
132 | Iovance Biotherapeutics Inc. | 0.05% | |
133 | MDGL | Madrigal Pharmaceuticals Inc. | 0.05% |
134 | BBIO | Bridgebio Pharma Inc. | 0.05% |
135 | Crinetics Pharmaceuticals Inc. | 0.05% | |
136 | ROIV | Roivant Sciences Ltd. | 0.05% |
137 | AMN Healthcare Services Inc. | 0.04% | |
138 | Teladoc Health Inc. | 0.04% | |
139 | Premier Inc. Class A | 0.04% | |
140 | Integra LifeSciences Holdings Corp. | 0.04% | |
141 | Tandem Diabetes Care Inc. | 0.04% | |
142 | Intellia Therapeutics Inc. | 0.04% | |
143 | Inari Medical Inc. | 0.04% | |
144 | ICU Medical Inc. | 0.04% | |
145 | Corcept Therapeutics Inc. | 0.04% | |
146 | RCM | R1 RCM Inc. | 0.04% |
147 | Beam Therapeutics Inc. | 0.04% | |
148 | Denali Therapeutics Inc. | 0.04% | |
149 | CONMED Corp. | 0.04% | |
150 | Patterson Cos. Inc. | 0.04% | |
151 | Arvinas Inc. | 0.04% | |
152 | Amicus Therapeutics Inc. | 0.04% | |
153 | Xenon Pharmaceuticals Inc. | 0.04% | |
154 | CorVel Corp. | 0.04% | |
155 | TransMedics Group Inc. | 0.04% | |
156 | Axsome Therapeutics Inc. | 0.04% | |
157 | Celldex Therapeutics Inc. | 0.04% | |
158 | Vericel Corp. | 0.04% | |
159 | RadNet Inc. | 0.04% | |
160 | TG Therapeutics Inc. | 0.04% | |
161 | SpringWorks Therapeutics Inc. | 0.04% | |
162 | Hims & Hers Health Inc. | 0.04% | |
163 | PROCEPT BioRobotics Corp. | 0.04% | |
164 | QuidelOrtho Corp. | 0.04% | |
165 | Guardant Health Inc. | 0.04% | |
166 | Ideaya Biosciences Inc. | 0.04% | |
167 | Novocure Ltd. | 0.03% | |
168 | agilon health Inc. | 0.03% | |
169 | Privia Health Group Inc. | 0.03% | |
170 | PTC Therapeutics Inc. | 0.03% | |
171 | Tilray Inc. | 0.03% | |
172 | ACADIA Pharmaceuticals Inc. | 0.03% | |
173 | Supernus Pharmaceuticals Inc. | 0.03% | |
174 | Twist Bioscience Corp. | 0.03% | |
175 | Addus HomeCare Corp. | 0.03% | |
176 | Myriad Genetics Inc. | 0.03% | |
177 | Veracyte Inc. | 0.03% | |
178 | Schrodinger Inc./United States | 0.03% | |
179 | Apollo Medical Holdings Inc. | 0.03% | |
180 | Agios Pharmaceuticals Inc. | 0.03% | |
181 | Certara Inc. | 0.03% | |
182 | Owens & Minor Inc. | 0.03% | |
183 | Amphastar Pharmaceuticals Inc. | 0.03% | |
184 | US Physical Therapy Inc. | 0.03% | |
185 | Surgery Partners Inc. | 0.03% | |
186 | Syndax Pharmaceuticals Inc. | 0.03% | |
187 | Rocket Pharmaceuticals Inc. | 0.03% | |
188 | NeoGenomics Inc. | 0.03% | |
189 | Kymera Therapeutics Inc. | 0.03% | |
190 | Keros Therapeutics Inc. | 0.03% | |
191 | Merus NV | 0.03% | |
192 | Avidity Biosciences Inc. | 0.03% | |
193 | Recursion Pharmaceuticals Inc. Class A | 0.03% | |
194 | Immunovant Inc. | 0.03% | |
195 | NUVL | Nuvalent Inc. Class A | 0.03% |
196 | Catalyst Pharmaceuticals Inc. | 0.03% | |
197 | Rhythm Pharmaceuticals Inc. | 0.03% | |
198 | Arcellx Inc. | 0.03% | |
199 | UFP Technologies Inc. | 0.03% | |
200 | Ardelyx Inc. | 0.03% | |
201 | Omnicell Inc. | 0.02% | |
202 | STAAR Surgical Co. | 0.02% | |
203 | Pacira BioSciences Inc. | 0.02% | |
204 | Prothena Corp. plc | 0.02% | |
205 | Sage Therapeutics Inc. | 0.02% | |
206 | AtriCure Inc. | 0.02% | |
207 | Maravai LifeSciences Holdings Inc. Class A | 0.02% | |
208 | Xencor Inc. | 0.02% | |
209 | Ironwood Pharmaceuticals Inc. Class A | 0.02% | |
210 | Ligand Pharmaceuticals Inc. | 0.02% | |
211 | Phreesia Inc. | 0.02% | |
212 | Harmony Biosciences Holdings Inc. | 0.02% | |
213 | Establishment Labs Holdings Inc. | 0.02% | |
214 | MannKind Corp. | 0.02% | |
215 | LeMaitre Vascular Inc. | 0.02% | |
216 | National HealthCare Corp. | 0.02% | |
217 | Kura Oncology Inc. | 0.02% | |
218 | Brookdale Senior Living Inc. | 0.02% | |
219 | Alphatec Holdings Inc. | 0.02% | |
220 | Sotera Health Co. | 0.02% | |
221 | Morphic Holding Inc. | 0.02% | |
222 | Collegium Pharmaceutical Inc. | 0.02% | |
223 | Sana Biotechnology Inc. | 0.02% | |
224 | Protagonist Therapeutics Inc. | 0.02% | |
225 | Akero Therapeutics Inc. | 0.02% | |
226 | ADMA Biologics Inc. | 0.02% | |
227 | RxSight Inc. | 0.02% | |
228 | Geron Corp. | 0.02% | |
229 | ANI Pharmaceuticals Inc. | 0.02% | |
230 | Alpine Immune Sciences Inc. | 0.02% | |
231 | Dynavax Technologies Corp. | 0.02% | |
232 | BioCryst Pharmaceuticals Inc. | 0.01% | |
233 | Pacific Biosciences of California Inc. | 0.01% | |
234 | Revance Therapeutics Inc. | 0.01% | |
235 | Relay Therapeutics Inc. | 0.01% | |
236 | Novavax Inc. | 0.01% | |
237 | Fate Therapeutics Inc. | 0.01% | |
238 | Vir Biotechnology Inc. | 0.01% | |
239 | Silk Road Medical Inc. | 0.01% | |
240 | AdaptHealth Corp. | 0.01% | |
241 | Cassava Sciences Inc. | 0.01% | |
242 | CryoPort Inc. | 0.01% | |
243 | Cross Country Healthcare Inc. | 0.01% | |
244 | Nevro Corp. | 0.01% | |
245 | Verve Therapeutics Inc. | 0.01% | |
246 | Travere Therapeutics Inc. | 0.01% | |
247 | Zentalis Pharmaceuticals Inc. | 0.01% | |
248 | Alignment Healthcare Inc. | 0.01% | |
249 | Arcus Biosciences Inc. | 0.01% | |
250 | Avid Bioservices Inc. | 0.01% | |
251 | Cytek Biosciences Inc. | 0.01% | |
252 | Allogene Therapeutics Inc. | 0.01% | |
253 | Varex Imaging Corp. | 0.01% | |
254 | Editas Medicine Inc. | 0.01% | |
255 | Aurinia Pharmaceuticals Inc. | 0.01% | |
256 | OPKO Health Inc. | 0.01% | |
257 | CareDx Inc. | 0.01% | |
258 | Enanta Pharmaceuticals Inc. | 0.01% | |
259 | Atrion Corp. | 0.01% | |
260 | Avanos Medical Inc. | 0.01% | |
261 | Anavex Life Sciences Corp. | 0.01% | |
262 | REGENXBIO Inc. | 0.01% | |
263 | Innoviva Inc. | 0.01% | |
264 | DocGo Inc. | 0.01% | |
265 | Fulgent Genetics Inc. | 0.01% | |
266 | Adaptive Biotechnologies Corp. | 0.01% | |
267 | Inhibrx Inc. | 0.01% | |
268 | BioLife Solutions Inc. | 0.01% | |
269 | Mesa Laboratories Inc. | 0.01% | |
270 | Cerus Corp. | 0.01% | |
271 | Deciphera Pharmaceuticals Inc. | 0.01% | |
272 | Simulations Plus Inc. | 0.01% | |
273 | Enhabit Inc. | 0.01% | |
274 | IBRX | ImmunityBio Inc. | 0.01% |
275 | Accolade Inc. | 0.01% | |
276 | Cogent Biosciences Inc. | 0.01% | |
277 | OrthoPediatrics Corp. | 0.01% | |
278 | HealthStream Inc. | 0.01% | |
279 | Agiliti Inc. | 0.01% | |
280 | Theravance Biopharma Inc. | 0.01% | |
281 | Castle Biosciences Inc. | 0.01% | |
282 | SI-BONE Inc. | 0.01% | |
283 | Viridian Therapeutics Inc. | 0.01% | |
284 | Inovio Pharmaceuticals Inc. | 0.01% | |
285 | Paragon 28 Inc. | 0.01% | |
286 | Clover Health Investments Corp. Class A | 0.01% | |
287 | Alector Inc. | 0.01% | |
288 | MaxCyte Inc. | 0.01% | |
289 | Replimune Group Inc. | 0.01% | |
290 | Surmodics Inc. | 0.01% | |
291 | Heron Therapeutics Inc. | 0.01% | |
292 | CryoLife Inc. | 0.01% | |
293 | Nurix Therapeutics Inc. | 0.01% | |
294 | Health Catalyst Inc. | 0.01% | |
295 | Arcturus Therapeutics Holdings Inc. | 0.01% | |
296 | SIGA Technologies Inc. | 0.01% | |
297 | Treace Medical Concepts Inc. | 0.01% | |
298 | Quanterix Corp. | 0.01% | |
299 | Pulmonx Corp. | 0.01% | |
300 | GoodRx Holdings Inc. Class A | 0.01% | |
301 | iTeos Therapeutics Inc. | 0.01% | |
302 | Ocugen Inc. | 0.01% | |
303 | Community Health Systems Inc. | 0.01% | |
304 | Kiniksa Pharmaceuticals Ltd. Class A | 0.01% | |
305 | Pennant Group Inc. | 0.01% | |
306 | Orthofix Medical Inc. | 0.01% | |
307 | OraSure Technologies Inc. | 0.01% | |
308 | Nuvation Bio Inc. | 0.01% | |
309 | Tango Therapeutics Inc. | 0.01% | |
310 | PetIQ Inc. Class A | 0.01% | |
311 | MiMedx Group Inc. | 0.01% | |
312 | Amneal Pharmaceuticals Inc. | 0.01% | |
313 | MacroGenics Inc. | 0.01% | |
314 | Cullinan Oncology Inc. | 0.01% | |
315 | Phathom Pharmaceuticals Inc. | 0.01% | |
316 | Zimvie Inc. | 0.01% | |
317 | Janux Therapeutics Inc. | 0.01% | |
318 | Y-mAbs Therapeutics Inc. | 0.01% | |
319 | Embecta Corp. | 0.01% | |
320 | Pliant Therapeutics Inc. | 0.01% | |
321 | Altimmune Inc. | 0.01% | |
322 | Tarsus Pharmaceuticals Inc. | 0.01% | |
323 | HilleVax Inc. | 0.01% | |
324 | OmniAb Inc. | 0.01% | |
325 | MEDNAX Inc. | 0.01% | |
326 | Definitive Healthcare Corp. Class A | 0.01% | |
327 | 89bio Inc. | 0.01% | |
328 | Biomea Fusion Inc. | 0.01% | |
329 | Day One Biopharmaceuticals Inc. | 0.01% | |
330 | Liquidia Technologies Inc. | 0.01% | |
331 | Disc Medicine Inc. | 0.01% | |
332 | Mirum Pharmaceuticals Inc. | 0.01% | |
333 | MoonLake Immunotherapeutics Class A | 0.01% | |
334 | Cabaletta Bio Inc. | 0.01% | |
335 | Evolus Inc. | 0.01% | |
336 | Summit Therapeutics Inc. | 0.01% | |
337 | Enliven Therapeutics Inc. | 0.01% | |
338 | Prime Medicine Inc. | 0.01% | |
339 | Fluidigm Corp. | 0.01% | |
340 | Harrow Inc. | 0.01% | |
341 | FibroGen Inc. | 0% | |
342 | ModivCare Inc. | 0% | |
343 | Emergent BioSolutions Inc. | 0% | |
344 | American Well Corp. Class A | 0% | |
345 | Seres Therapeutics Inc. | 0% | |
346 | uniQure NV | 0% | |
347 | Cutera Inc. | 0% | |
348 | Agenus Inc. | 0% | |
349 | Nektar Therapeutics Class A | 0% | |
350 | Vanda Pharmaceuticals Inc. | 0% | |
351 | Sangamo Therapeutics Inc. | 0% | |
352 | 2seventy bio Inc. | 0% | |
353 | Gossamer Bio Inc. | 0% | |
354 | Butterfly Network Inc. | 0% | |
355 | Multiplan Corp. | 0% | |
356 | AngioDynamics Inc. | 0% | |
357 | Ventyx Biosciences Inc. | 0% | |
358 | Coherus Biosciences Inc. | 0% | |
359 | RAPT Therapeutics Inc. | 0% | |
360 | Inogen Inc. | 0% | |
361 | AnaptysBio Inc. | 0% | |
362 | Atea Pharmaceuticals Inc. | 0% | |
363 | Cara Therapeutics Inc. | 0% | |
364 | Eagle Pharmaceuticals Inc./DE | 0% | |
365 | Atara Biotherapeutics Inc. | 0% | |
366 | ATAI Life Sciences NV | 0% | |
367 | CareMax Inc. | 0% | |
368 | Codexis Inc. | 0% | |
369 | Seer Inc. Class A | 0% | |
370 | Phibro Animal Health Corp. Class A | 0% | |
371 | Repare Therapeutics Inc. | 0% | |
372 | Quantum-Si Inc. | 0% | |
373 | PMV Pharmaceuticals Inc. | 0% | |
374 | OptimizeRx Corp. | 0% | |
375 | Erasca Inc. | 0% | |
376 | Stoke Therapeutics Inc. | 0% | |
377 | ALX Oncology Holdings Inc. | 0% | |
378 | Vaxart Inc. | 0% | |
379 | IGM Biosciences Inc. | 0% | |
380 | Humacyte Inc. | 0% | |
381 | MeiraGTx Holdings plc | 0% | |
382 | Monte Rosa Therapeutics Inc. | 0% | |
383 | NGM Biopharmaceuticals Inc. | 0% | |
384 | Nautilus Biotechnology Inc. | 0% | |
385 | Aveanna Healthcare Holdings Inc. | 0% | |
386 | Organogenesis Holdings Inc. Class A | 0% | |
387 | Foghorn Therapeutics Inc. | 0% | |
388 | Century Therapeutics Inc. | 0% | |
389 | Aclaris Therapeutics Inc. | 0% | |
390 | Senseonics Holdings Inc. | 0% | |
391 | Entrada Therapeutics Inc. | 0% | |
392 | Aerovate Therapeutics Inc. | 0% | |
393 | Akoya Biosciences Inc. | 0% | |
394 | Outset Medical Inc. | 0% | |
395 | 23andMe Holding Co. Class A | 0% | |
396 | Amylyx Pharmaceuticals Inc. | 0% | |
397 | Aldeyra Therapeutics Inc. | 0% | |
398 | Sharecare Inc. | 0% | |
399 | Lyell Immunopharma Inc. | 0% | |
400 | Terns Pharmaceuticals Inc. | 0% | |
401 | Bionano Genomics Inc. | 0% | |
402 | PDL BioPharma Inc. | 0% | |
403 | Mural Oncology plc | 0% | |
404 | ACELYRIN Inc. | 0% | |
405 | SCILEX HOLDING CO - RESTRICTED LINE | 0% |
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。